A New Track Ablation Device for Liver Biopsy: A Feasibility Study

Clinical trial NCT02521129 · UNKNOWN

Trial details

NCT number: NCT02521129
Sponsor: Samsung Medical Center
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Liver Neoplasms

Start date: 2015-09-01
Primary completion: 2016-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.